Prof Chris Jones

27 Development of Precision Virotherapies for Diffuse Midline Gliomas

Abstract Introduction Diffuse Midline Gliomas (DMGs) are highly aggressive paediatric brainstem tumours with a median survival of 9-11 months - a figure unchanged for over four decades. This indicates a critical need for targeted therapies. The VITAL lab has developed Ad5NULL-RGD...